Taking stimulant medications to treat attention deficit hyperactivity disorder (ADHD) during the first trimester of pregnancy is unlikely to cause major birth defects with one possible exception, suggests a new study. Researchers found no increased risks for amphetamines medication, but they found a small increased risk for congenital heart defects in newborns exposed to methylphenidate in the first trimester.